WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007083133) TREATMENT OF NERVE DAMAGE BY MODULATION OF CELLULAR ALPHA 9 INTEGRIN LEVELS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/083133    International Application No.:    PCT/GB2007/000167
Publication Date: 26.07.2007 International Filing Date: 19.01.2007
IPC:
A61K 38/17 (2006.01)
Applicants: CAMBRIDGE ENTERPRISE LIMITED [GB/GB]; The Old Schools, Trinity Lane, Cambridge, Cambridgeshire CB2 1TN (GB) (For All Designated States Except US).
FAWCETT, James [GB/GB]; (GB) (For US Only).
FFRENCH-CONSTANT, Charles [GB/GB]; (GB) (For US Only).
VOGELEZANG, Mariette, Geertruida [NL/US]; (US) (For US Only).
CZVITKOVICH, Stefan [AT/GB]; (GB) (For US Only)
Inventors: FAWCETT, James; (GB).
FFRENCH-CONSTANT, Charles; (GB).
VOGELEZANG, Mariette, Geertruida; (US).
CZVITKOVICH, Stefan; (GB)
Agent: SUTCLIFFE, Nicholas; Mewburn Ellis LLP, York House, 23 Kingsway, London, Greater London WC2B 6HP (GB)
Priority Data:
0601200.9 20.01.2006 GB
Title (EN) TREATMENT OF NERVE DAMAGE BY MODULATION OF CELLULAR ALPHA 9 INTEGRIN LEVELS
(FR) TRAITEMENT DE LÉSION DE NERFS PAR MODULATION DE NIVEAUX CELLULAIRES D'INTÉGRINE ALPHA 9
Abstract: front page image
(EN)The invention relates to the treatment of damaged nerves by increasing the level or amount of integrin α 9 in neural cells, such as neurons or Schwann cells, to promote the regeneration of neuronal axons and the migration of Schwann cells within the damaged tissue.
(FR)La présente invention concerne le traitement de nerfs lésés par augmentation du niveau ou de la quantité d'intégrine α9 dans des cellules neuronales, telles que des neurones ou des cellules de Schwann, pour favoriser la régénération d'axones neuronaux et la migration de cellules de Schwann dans les tissus lésés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)